We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
-0.64%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$235M
AUM Growth
-$6.24M
Cap. Flow
-$3.92M
Cap. Flow %
-1.67%
Top 10 Hldgs %
31.41%
Holding
105
New
1
Increased
12
Reduced
59
Closed
3

Top Sells

Rank Stock Value
1
DYAX
DYAX CORPORATION
DYAX
+$679K
2
DE icon
Deere & Co
DE
+$581K
3
ABB
ABB Ltd
ABB
+$319K
4
PEP icon
PepsiCo
PEP
+$307K
5
CVS icon
CVS Health
CVS
+$257K

Sector Composition

Rank Sector Weight
1 Healthcare 21.15%
2 Technology 19.47%
3 Industrials 18.63%
4 Energy 9.95%
5 Consumer Staples 7.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CI icon
51
Cigna
CI
$75.1B
$977K 0.42%
6,030
KO icon
52
Coca-Cola
KO
$353B
$935K 0.4%
23,815
-1,600
-6% -$65.1K
ILMN icon
53
Illumina
ILMN
$27.9B
$932K 0.4%
4,390
+2
+0% +$391
DYAX
54
DELISTED
DYAX CORPORATION
DYAX
$904K 0.39%
34,100
-25,629
-43% -$679K
IONS icon
55
Ionis Pharmaceuticals
IONS
$8.75B
$902K 0.38%
15,657
ABB
56
DELISTED
ABB Ltd
ABB
$849K 0.36%
40,621
-14,540
-26% -$319K
COP icon
57
ConocoPhillips
COP
$141B
$751K 0.32%
12,235
-30
-0.2% -$1.96K
TT icon
58
Trane Technologies
TT
$103B
$629K 0.27%
9,326
PFE icon
59
Pfizer
PFE
$141B
$600K 0.26%
18,828
-2,006
-10% -$65.4K
ALNY icon
60
Alnylam Pharmaceuticals
ALNY
$36.4B
$597K 0.25%
4,987
-40
-0.8% -$4.78K
UL icon
61
Unilever
UL
$133B
$585K 0.25%
+12,102
New +$598K
CYN
62
DELISTED
CITY NATIONAL CORPORATION
CYN
$498K 0.21%
5,510
-75
-1% -$6.93K
PSX icon
63
Phillips 66
PSX
$83.7B
$487K 0.21%
6,036
MCD icon
64
McDonald's
MCD
$190B
$485K 0.21%
5,100
-200
-4% -$19.3K
GIS icon
65
General Mills
GIS
$20.1B
$461K 0.2%
8,275
-3,275
-28% -$183K
KMB icon
66
Kimberly-Clark
KMB
$36B
$453K 0.19%
4,274
-122
-3% -$13.3K
CSX icon
67
CSX Corp
CSX
$93.1B
$382K 0.16%
35,100
BAX icon
68
Baxter International
BAX
$11.4B
$380K 0.16%
10,011
LLY icon
69
Eli Lilly
LLY
$1.02T
$376K 0.16%
4,500
-100
-2% -$7.62K
STT icon
70
State Street
STT
$50.2B
$364K 0.16%
4,724
-144
-3% -$11.2K
TMO icon
71
Thermo Fisher Scientific
TMO
$196B
$337K 0.14%
2,603
NEE icon
72
NextEra Energy
NEE
$184B
$328K 0.14%
13,360
-2,000
-13% -$50.8K
WMT icon
73
Walmart Inc
WMT
$893B
$278K 0.12%
11,778
-384
-3% -$9.79K
STKL
74
DELISTED
SunOpta
STKL
$258K 0.11%
23,955
-900
-4% -$9.51K
CAT icon
75
Caterpillar
CAT
$398B
$256K 0.11%
3,024

Similar funds

Brian C. Broderick's Q2 2015 Portfolio in Review

As of Q2 2015, Brian C. Broderick held 105 positions worth $235M, down 2.6% from $241M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Trading was light in Q2 2015: portfolio turnover was 3.8%. Brian C. Broderick opened 1 new position and exited 3, leaving the 105-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.

  • Brian C. Broderick's largest Q2 2015 buy was Unilever: 12,102 shares worth $585K.
  • Brian C. Broderick added most to Alphabet (Google) Class C in Q2 2015, an estimated $462K increase.
  • Brian C. Broderick's biggest Q2 2015 reduction was DYAX CORPORATION, cutting an estimated $679K.
  • Brian C. Broderick fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q2 2015, selling an estimated $29K.
  • Brian C. Broderick's ten largest holdings make up 31% of its $235M portfolio in Q2 2015.
  • Brian C. Broderick opened 1 new position and closed 3 in Q2 2015.
  • Brian C. Broderick's portfolio value fell 2.6% quarter-over-quarter to $235M.

Based on Brian C. Broderick's 13F filing for Q2 2015, filed 10 Aug 2015.